Literature DB >> 17968311

Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity.

P-J Yu1, G Ferrari, L Pirelli, A C Galloway, P Mignatti, G Pintucci.   

Abstract

The fgf-2 gene encodes low molecular weight (LMW, 18 kDa) and high molecular weight (HMW, 22-24 kDa) forms that originate from alternative translation of a single mRNA and exhibit diverse biological functions. HMW fibroblast growth factor-2 (FGF-2) inhibits cell migration and induces cell transformation or growth arrest in a cell type- and dose-dependent fashion. Conversely, LMW FGF-2 upregulates both cell proliferation and migration in most cell types. Although transcriptional and translational regulation of HMW and LMW FGF-2 has been extensively investigated, little is known about post-translational control of their relative expression. Here we report that thrombin, a key coagulation factor and inflammatory mediator, cleaves HMW FGF-2 into an LMW FGF-2-like form that stimulates endothelial cell migration and proliferation. The effect of thrombin on these cell functions requires HMW FGF-2 cleavage. This post-translational control mechanism adds a novel level of complexity to the regulation of FGF-2, and links the activities of thrombin and FGF-2 in patho-physiological processes in which both molecules are expressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968311      PMCID: PMC3727294          DOI: 10.1038/sj.onc.1210899

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Evolution of the Fgf and Fgfr gene families.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

2.  Thrombin: can't live without it; probably die from it.

Authors:  Kenneth G Mann
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

3.  Thrombin stimulates c-sis gene expression in microvascular endothelial cells.

Authors:  T O Daniel; V C Gibbs; D F Milfay; M R Garovoy; L T Williams
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

Review 4.  Tissue factor, thrombin, and cancer.

Authors:  Frederick R Rickles; Steven Patierno; Patricia M Fernandez
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

5.  Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease.

Authors:  Peter Claus; Stefan Werner; Marco Timmer; Claudia Grothe
Journal:  Neurosci Lett       Date:  2004-04-29       Impact factor: 3.046

6.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

7.  Expression of proteinase-activated receptors in mouse microglial cells.

Authors:  Stephanie Balcaitis; Yiheng Xie; Jonathan R Weinstein; Henrik Andersen; Uwe-Karsten Hanisch; Bruce R Ransom; Thomas Möller
Journal:  Neuroreport       Date:  2003-12-19       Impact factor: 1.837

8.  Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.

Authors:  Bernhard H Rauch; Esther Millette; Richard D Kenagy; Guenter Daum; Alexander W Clowes
Journal:  Circ Res       Date:  2003-12-11       Impact factor: 17.367

9.  Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor.

Authors:  R R Lobb
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

10.  Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells.

Authors:  Simona Taverna; Giulio Ghersi; Angela Ginestra; Salvatrice Rigogliuso; Sonia Pecorella; Giovanna Alaimo; Francesca Saladino; Vincenza Dolo; Patrizia Dell'Era; Antonio Pavan; Giuseppe Pizzolanti; Paolo Mignatti; Marco Presta; Maria Letizia Vittorelli
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  7 in total

1.  Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection.

Authors:  Jung Hwa Kim; Shaobo Jiang; Cherilyn A Elwell; Joanne N Engel
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

Review 2.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

Review 3.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

4.  Protein targets of inflammatory serine proteases and cardiovascular disease.

Authors:  Ram Sharony; Pey-Jen Yu; Joy Park; Aubrey C Galloway; Paolo Mignatti; Giuseppe Pintucci
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

5.  High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling.

Authors:  Jon-Jon Santiago; Leslie J McNaughton; Navid Koleini; Xin Ma; Brian Bestvater; Barbara E Nickel; Robert R Fandrich; Jeffrey T Wigle; Darren H Freed; Rakesh C Arora; Elissavet Kardami
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 6.  Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies.

Authors:  Mohamed R Akl; Poonam Nagpal; Nehad M Ayoub; Betty Tai; Sathyen A Prabhu; Catherine M Capac; Matthew Gliksman; Andre Goy; K Stephen Suh
Journal:  Oncotarget       Date:  2016-07-12

7.  Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice.

Authors:  Lin Wang; Xi-Xi Li; Xi Chen; Xiao-Yan Qin; Elissavet Kardami; Yong Cheng
Journal:  Front Mol Neurosci       Date:  2018-10-12       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.